However, genetic and pharmacological inhibition of RAD51 further sensitized BL0479-72 cells to TMZ + VE821 compared to control cells (Figure 4H), in line with the notion that HR deficiencies increase reliance on ATR activity in cancer cells [28]. The gene discussed is RAD51; the disease is cancer.